Analysis KMB
Kimberly-Clark's Kenvue deal is done. Integration will take $3.9 billion in cash.
The annual profit-benefit target is unchanged. A new filing details the cash and capital spending planned through 2029.
Kimberly-Clark has completed its acquisition of Kenvue and laid out the cost of bringing the businesses together. Its integration program is expected to involve about $3.9 billion of cash spending through the end of 2029.
The November 2 closing brings brands such as Huggies and Kleenex together with Tylenol, Listerine and Neutrogena. The next stage is the work needed to deliver the annual profit benefits Kimberly-Clark has targeted since the deal was announced.
The cash plan is bigger than the accounting charges alone suggest
Research by Ticker Byline shows that the planned cash spending consists of $2.5 billion of integration charges and another $1.4 billion of capital investment. The filing separately includes $600 million of noncash charges.
| Integration plan through 2029 | USD billions |
|---|---|
| Expected cash charges | 2.5 |
| Additional capital spending | 1.4 |
| Total expected cash spending | 3.9 |
| Separate noncash charges | 0.6 |
The largest cash items include $800 million for supply-chain changes, $600 million for technology integration and $400 million for workforce changes. The program began at closing and is expected to finish by December 31, 2029.
The annual benefit target is unchanged
Kimberly-Clark still targets $2.1 billion of annual profit benefits once the combination is fully implemented. That includes $1.9 billion of cost savings and $500 million of profit from additional sales, offset by $300 million of reinvestment.
The company targets the cost savings within three years after closing and the sales-related profit within four. These are annual benefits once achieved; the $3.9 billion spending plan covers the integration period.
The original November 2025 announcement already allowed for $2.5 billion of cash costs, expected in the first two years after closing. The new filing details a program running through 2029 and identifies the additional capital investment separately.
New shares and borrowing are already part of the deal
Each former Kenvue share converts into $3.50 in cash and 0.14625 Kimberly-Clark shares. The stock portion involves approximately 281.1 million Kimberly-Clark shares.
Kimberly-Clark completed a $4.9 billion senior-note issue on October 29, with proceeds intended in part for the acquisition and related costs. Those borrowings arrive before the projected integration benefits have been delivered.
The Kimberly-Clark company profile records the completed acquisition, integration targets and latest available financial histories for both legacy businesses.